The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients - Publication - Bridge of Knowledge

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients

Abstract

Citations

2 2

CrossRef
0

Web of Science
1 9

Scopus

Authors (12)

Paweł Robak
Izabela Dróżdż
Dariusz Jarych
Damian Mikulski
Edyta Węgłowska
Monika Siemieniuk-Ryś
Małgorzata Misiewicz
Konrad Stawiski dr n. med.
Wojciech Fendler
Janusz Szemraj
Piotr Smolewski
Tadeusz Robak

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: Cancers no. 12, edition 9,
ISSN: 2072-6694
ISSN:: 2072-6694
Publication year:: 2020
DOI:: Digital Object Identifier (open in new tab) 10.3390/cancers12092569
Verified by:: No verification

seen 71 times